gatifloxacin has been researched along with Absence Status in 2 studies
Gatifloxacin: A fluoroquinolone antibacterial agent and DNA TOPOISOMERASE II inhibitor that is used as an ophthalmic solution for the treatment of BACTERIAL CONJUNCTIVITIS.
gatifloxacin : A monocarboxylic acid that is 4-oxo-1,4-dihydroquinoline-3-carboxylic acid which is substituted on the nitrogen by a cyclopropyl group and at positions 6, 7, and 8 by fluoro, 3-methylpiperazin-1-yl, and methoxy groups, respectively. Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial topoisomerase type-II enzymes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report two old ladies presenting with generalized status epilepticus after being treated orally with normal doses of gatifloxacin, with a good recovery." | 7.74 | [Status epilepticus and gatifloxacin]. ( Hage Chahine, S; Koussa, S; Yazbeck, P; Zoghbi, A, 2007) |
| "We report two old ladies presenting with generalized status epilepticus after being treated orally with normal doses of gatifloxacin, with a good recovery." | 3.74 | [Status epilepticus and gatifloxacin]. ( Hage Chahine, S; Koussa, S; Yazbeck, P; Zoghbi, A, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koussa, SF | 1 |
| Chahine, SL | 1 |
| Samaha, EI | 1 |
| Riachi, MA | 1 |
| Koussa, S | 1 |
| Hage Chahine, S | 1 |
| Zoghbi, A | 1 |
| Yazbeck, P | 1 |
2 other studies available for gatifloxacin and Absence Status
| Article | Year |
|---|---|
Generalized status epilepticus possibly induced by gatifloxacin.
Topics: Aged; Anti-Bacterial Agents; Female; Fluoroquinolones; Gatifloxacin; Humans; Status Epilepticus; Uri | 2006 |
[Status epilepticus and gatifloxacin].
Topics: Aged; Anti-Infective Agents; Female; Fluoroquinolones; Gatifloxacin; Humans; Status Epilepticus | 2007 |